rs17406681

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005235.3(ERBB4):​c.2487+23241G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.18 in 151,700 control chromosomes in the GnomAD database, including 3,037 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.18 ( 3037 hom., cov: 32)

Consequence

ERBB4
NM_005235.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.117

Publications

6 publications found
Variant links:
Genes affected
ERBB4 (HGNC:3432): (erb-b2 receptor tyrosine kinase 4) This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]
ERBB4 Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis type 19
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005235.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.233 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005235.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ERBB4
NM_005235.3
MANE Select
c.2487+23241G>A
intron
N/ANP_005226.1Q15303-1
ERBB4
NM_001439005.1
c.2457+23241G>A
intron
N/ANP_001425934.1
ERBB4
NM_001042599.2
c.2487+23241G>A
intron
N/ANP_001036064.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ERBB4
ENST00000342788.9
TSL:1 MANE Select
c.2487+23241G>A
intron
N/AENSP00000342235.4Q15303-1
ERBB4
ENST00000436443.5
TSL:1
c.2487+23241G>A
intron
N/AENSP00000403204.1Q15303-3
ERBB4
ENST00000260943.11
TSL:5
c.2457+23241G>A
intron
N/AENSP00000260943.7Q15303-4

Frequencies

GnomAD3 genomes
AF:
0.180
AC:
27341
AN:
151582
Hom.:
3030
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0671
Gnomad AMI
AF:
0.227
Gnomad AMR
AF:
0.233
Gnomad ASJ
AF:
0.222
Gnomad EAS
AF:
0.109
Gnomad SAS
AF:
0.0855
Gnomad FIN
AF:
0.240
Gnomad MID
AF:
0.222
Gnomad NFE
AF:
0.236
Gnomad OTH
AF:
0.226
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.180
AC:
27374
AN:
151700
Hom.:
3037
Cov.:
32
AF XY:
0.178
AC XY:
13160
AN XY:
74112
show subpopulations
African (AFR)
AF:
0.0674
AC:
2796
AN:
41476
American (AMR)
AF:
0.234
AC:
3554
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.222
AC:
768
AN:
3458
East Asian (EAS)
AF:
0.109
AC:
561
AN:
5152
South Asian (SAS)
AF:
0.0869
AC:
419
AN:
4824
European-Finnish (FIN)
AF:
0.240
AC:
2511
AN:
10484
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.236
AC:
16027
AN:
67776
Other (OTH)
AF:
0.222
AC:
468
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1097
2193
3290
4386
5483
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
290
580
870
1160
1450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.220
Hom.:
15897
Bravo
AF:
0.179
Asia WGS
AF:
0.104
AC:
361
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
1.3
DANN
Benign
0.72
PhyloP100
0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs17406681;
hg19: chr2-212403387;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.